Enhance Your Success in the Business of Biotech - Try BioWorld Today!

This is a paid advertisement for SmartBrief readers.

The content does not necessarily reflect the view of SmartBrief or its Association partners.

If you are having trouble viewing this message in your e-mail client, please see the web version here

Enhance your success in the business of biotech with BioWorld Today, the industry's most respected news source for more than 20 years. Delivering insider intelligence every business morning, you get the latest details on a wide range of issues dramatically affecting the industry. BioWorld Today includes coverage of: Therapeutic product development from early to late stage, strategic alliances, mergers and acquisitions, corporate financings both public and private, biotech company advancements and setbacks, scientific milestones, global regulatory updates, profiles of new and mature biotech and speciality pharmaceutical firms, big pharma's growing involvement in biotech, plus much more! Just take a look at what's covered in this week's issue: Glybera Gains Official EMA Nod as First Gene Therapy Portola, BMS, Pfizer Team Up to Test Their Drugs Antidote Provenge Sales Disappoint But Dendreon Shows Growth Ziarco Launches with $27M Series A, Assets from Pfizer Supremes to Hear Arguments on 'Fraud-on-the-Market' Claims That's not all, with BioWorld Today you'll get the inside track on: What your competitors are doing ... so you can easily identify opportunities and threats. Where the smart money is going ... where top investors are placing their bets and who is raising funds. The latest technological innovations and discoveries ... to clinical study results across the industry. What the FDA and Congress are up to ... so you can prepare for coming changes and recent approvals. With writers and editors stationed around the globe, BioWorld Today provides the critical news and insights you need to be competitive in this industry! Access your free issue now!

About this email: BIO SmartBrief will occasionally send emails from our advertising partners promoting products and services determined to be of interest and relevance to our readers. Each email is carefully considered on a case-by-case basis. If you do not want to receive these emails, you can unsubscribe from them by clicking here. SmartBrief, Inc.® 555 11th ST NW, Suite 600, Washington, DC 20004